Publicaciones en las que colabora con RAQUEL EMILIA RODRÍGUEZ RODRÍGUEZ (23)

2006

  1. New kappa opioid receptor from zebrafish Danio rerio

    Neuroscience Letters, Vol. 405, Núm. 1-2, pp. 94-99

2004

  1. Bases genéticas del dolor

    Revista de la Sociedad Espanola del Dolor, Vol. 11, Núm. 7, pp. 444-451

2003

  1. Characterization of zebrafish proenkephalin reveals novel opioid sequences

    Molecular Brain Research, Vol. 114, Núm. 1, pp. 31-39

  2. Cloning and characterization of a full-length pronociceptin in zebrafish: Evidence of the existence of two different nociceptin sequences in the same precursor

    Biochimica et Biophysica Acta - Gene Structure and Expression, Vol. 1629, Núm. 1-3, pp. 114-118

  3. Growth hormone expression in ontogenic development in gilthead sea bream

    Cell and Tissue Research, Vol. 313, Núm. 1, pp. 81-91

  4. Identification of two proopiomelanocortin genes in zebrafish (Danio rerio)

    Molecular Brain Research, Vol. 120, Núm. 1, pp. 1-8

2002

  1. Bases genéticas de las enfermedades hereditarias

    Medicine: Programa de Formación Médica Continuada Acreditado, Vol. 8, Núm. 82, pp. 4414-4421

2001

  1. Estudio del gen HFE en una familia Española con hemocromatosis hereditaria

    Medicina Clinica, Vol. 116, Núm. 3, pp. 100-103

1999

  1. Expression of ZFOR1, a δ-opioid receptor, in the central nervous system of the zebrafish (Danio rerio)

    Journal of Comparative Neurology, Vol. 412, Núm. 3, pp. 429-438

1998

  1. Cloning, molecular characterization, and distribution of a gene homologous to δ opioid receptor from zebrafish (Danio rerio)

    Biochemical and Biophysical Research Communications, Vol. 245, Núm. 2, pp. 544-548

  2. Genomic characterization of the human trkC gene

    Oncogene, Vol. 17, Núm. 14, pp. 1871-1875

1991

  1. Synthesis and biological activity of O-glycosylated morphiceptin analogues

    Journal of the Chemical Society, Perkin Transactions 1, pp. 1755-1759

1990

  1. Antinociceptive activity of glycosidic enkephalin analogues

    Psychopharmacology, Vol. 101, Núm. 2, pp. 222-225